Lawyers at national law firm Clarke Willmott have advised on a multi-million-pound investment in utilities and infrastructure software platform Business Modelling Applications (BMA).
Specialist software, data and services-focused growth investor, FPE, has invested in Leeds-based BMA, a leading software and services platform that provides intelligence for utility companies and asset-intensive infrastructure operators.
Founded in 2013, BMA has developed Decisio, a proprietary decision intelligence platform that helps regulated, asset-intensive operators understand their assets and then plan and prioritise long-term capital investment.
BMA’s customers include UK water and energy companies, who use Decisio to model trade-offs across cost, benefit, risk and carbon as they prepare multi-year regulatory business plans.
The business is well positioned to benefit from major UK utility investment cycles, including AMP8 in water and the RIIO frameworks in energy, where operators are under sustained pressure to deliver better outcomes at lower cost and demonstrate value for money to regulators.
With FPE’s support, the business will accelerate product and technology development, build out its executive team and invest in its go-to-market function to expand its presence across UK utilities and into other regulated infrastructure markets.
A multi-office team of lawyers at Clarke Willmott acted for BMA, led by Elinor Owen, a partner in the firm’s corporate team.
Also involved were corporate partner Simon Smith, Chris Connors (tax) and employment partner Kathryn Walters.
Rod Stout, founder and Board Advisor at BMA commented: “Clarke Willmott were fantastic to work with from start to finish. The team were always on hand when we needed them, their deal experience and pragmatic approach certainly helped us navigate the process with confidence. We greatly valued Elinor and the team’s support and would not hesitate to recommend Clarke Willmott to others considering a corporate transaction.”
Elinor Owen, partner at Clarke Willmott added “The Clarke Willmott team were delighted to act for the founders of BMA on the transaction, which will allow the business they have grown and nurtured to date to continue to scale.”
